The story of Sildenafil presents a nuanced case for observers in the medicinal sector. While initially a blockbuster success, generating huge profits, the patent end and the subsequent entry of cheaper versions have https://knockoff884564.buyoutblog.com/41807544/the-little-copyright-and-pharma-a-speculative-play